Search for:
Search for:
Healthcare Professionals
Publications
News
EspaƱol
Contact
Magazine
Radio
Get Educated
What is MS?
A chronic neurological disorder that affects the central nervous system, comprised of the brain...
More Details
Educational Materials
Common Questions
Lending Library
Symptoms
Treatment Options
Additional Resources
Research
MS Awareness Month
Donate
Get Help
Health & Wellness Program
Get educational materials and referrals, as well as the opportunity to participate in various...
Learn More
Grants & Programs
Awareness Campaigns
Support Groups
Events
Lending Library
Additional Resources
Get Involved
MS Awareness Month
An annual, nationwide campaign with goals to promote an understanding of MS, and to assist those...
Learn More
Advocacy
Buy from Partners
Volunteer
Businesses
MS Research Trials
Outreach
Awareness Campaigns
Host an Event
Events
Test Flyout
lorem ipsum dolor sit lorem ipsum dolor sit lorem ipsum dolor sit lorem ipsum dolor sit lorem...
Learn More
Events Calendar
Health & Wellness
Fundraisers
Support
Web & Teleconferences
MS Education
Host an Event
About Us
Programs & Grants
More Details
Overview
Press Room
Leadership
Financial Statements
Our Mission
Careers at MS Focus
Affiliations
News & Features
MS Focus At Sea
MS Focus At Sea offers educational programs, opportunities to meet old and new friends, and adventures for every...
/Events/MSF-Events/MSFocus-Cruise-For-A-Cause
Health and Wellness Grant
The MS Focus Health and Wellness Program offers adaptive exercise and wellness education in safe,...
/Get-Help/MSF-Programs-Grants/Health-and-Wellness-Program
Shop
Privacy
Terms of Use
Site Map
Study uncovers role of a protein in myelin-forming cells
July 20, 2018
Myelin – a membrane produced by specialized glial cells – plays a critical role in protecting the fibers that help carry messages throughout the body. In the central nervous system, glial cells known as oligodendrocytes are responsible for producing myelin. New findings have uncovered the role of a protein known as PRMT5 in the production of myelin.
From infancy through adolescence, myelinating oligodendrocytes are generated in abundance in the human brain by progenitor cells in a process that is highly sensitive to hormones, nutrients, and environmental conditions. In the adult brain, these progenitors cells serve as a reservoir for the generation of new myelin in response to learning and social experiences, or to repair myelin loss after injury (e.g. after immune attack to myelin, as in multiple sclerosis).
The molecular mechanisms that generate myelin-forming oligodendrocytes are only partially understood. Scientists at the Advanced Science Research Center at The Graduate Center of the City University of New York have pinpointed PRMT5 as a protein that essentially acts as a traffic cop, allowing progenitor cells to become oligodendrocytes and stopping the biological signals that would interfere with myelin production. PRMT5 promotes new myelin formation by acting on histones (proteins bound to DNA) and placing marks, which preclude the formation of obstacles to the differentiation of progenitor cells.
Researchers used three methods to eliminate PRMT5 and determine its role in myelin production in laboratory mice. First, they used CRISPR genetic ablation to target and eliminate the gene that produces PRMT5. In the second cohort, they used a pharmacological inhibitor to block activity of the protein. In the final cohort, they studied a group of knock-out mice who were born without the PRMT5-producing gene.
In each case, removing or blocking PRMT5 resulted in reduced progenitor cell differentiation and death of the cells that were attempting to become myelin producers.
The researchers’ findings show that blocking lysine acetyltransferases can favor myelin formation and also overcome the effect of PRMT5 inhibitors. These findings could be critical to improving the survival of patients with malignancies that need to be treated with PRMT5 inhibitors.
Results of mouse model studies sometimes do not translate to humans and may be years away from being a marketable treatment. However, the researchers said the discovery is a major step toward understanding the mechanisms of myelin production and the potential for treating certain central nervous system diseases.
The studies were published in the journal
Nature Communications
.
MS Focus Lending Library
Books, DVDs, and CDs are available for loan, by mail across the United States.
Learn more